44°
Feels Like: 42°
64°
41°
67°
By Andrew M. Seaman NEW YORK (Reuters Health) - Men who get an older and less costly form of radiation after their cancerous prostat...
Read More »By Ivan Oransky NEW YORK (Reuters Health) - The importance of health literacy hit home for Lisa Gualtieri when a Cambodian refugee d...
Read More »
FRANKFURT (Reuters) - Bayer said extended use of its experimental riociguat pill to treat a life-threatening form of high blood pres...
Read More »
By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to...
Read More »By Ben Hirschler and Tom Bill LONDON (Reuters) - AstraZeneca is closing in on a site for its new $500 million home in Cambridge, wit...
Read More »By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc ...
Read More »(Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a lat...
Read More »By Toni Clarke WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to r...
Read More »By Vrinda Manocha (Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned...
Read More »By Caroline Humer and Ransdell Pierson (Reuters) - Generic drugmaker Actavis Inc, itself a recent takeover target, said on Monday it...
Read More »
